Skip to content
Profiles

BrainXell

At BrainXell, they produce cells of the nervous system (brain and spinal cord) from control and patient human Induced Pluripotent Stem Cells (iPSCs). BrainXell has partnered with CMTA to produce spinal motor neurons from a CMT patient line provided to them via the NYSCF. These cells are to be used in drug discovery screens/assays to identify potentially therapeutic agents for CMT.